Understand the source comparison
Thymalin Dosage: Research Protocol Comparison
The table below compares Thymalin dosing parameters across common research applications, showing how reconstitution concentration, injection volume, and dosing frequency vary by study objective. Acute immune challenge model (small animal) 5mg per dose 5mg/mL (
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- The table below compares Thymalin dosing parameters across common research applications, showing how reconstitution concentration, injection volume, and dosing frequency vary by study objective.
- Acute immune challenge model (small animal)
- 5mg per dose
- 5mg/mL (10mg vial + 2mL water)
- 1mL subcutaneous
- Once daily
- 5 days
- Standard short-duration protocol for models evaluating immune response to pathogen exposure or surgical stress. Total cumulative dose 25mg
- Age-related immune decline study (human equivalent dose)
- 10mg per dose
- 10mg/mL (10mg vial + 1mL water)
- 10 days
- Most common dosing in published thymic peptide research. Balances injection volume convenience with therapeutic effect. Total cumulative dose 100mg
- High-dose immune reconstitution protocol
- 20mg per dose
- 10mg/mL (20mg vial + 2mL water)
- 2mL subcutaneous (single site) or 1mL × 2 sites
- Used in severe immune compromise models. Requires larger vial size to maintain practical reconstitution concentration. Total cumulative dose 200mg
- Body weight-scaled protocol (0.15mg/kg)
- Variable (10.5mg for 70kg subject)
- 2.1mL subcutaneous
- 7-10 days
- Scaling approach ensures dose consistency across subjects of different sizes within the same cohort. Fractional mL dosing requires precision syringe